National and Kapodistrian University of Athens
Η επίδραση της χορήγησης φιναστερίδης στην αγγείωση του προστάτη
Abstract
dc:descriptionThe aim of the present study is to assess the effects of finasteride on angiogenetic and hypoxia markers in benign prostatic hyperplasia (BPH). Our material consisted of one hundred and seventy eight patients aged 51-85 years (mean 68.7), suffering from BPH and awaiting treatment by transurethral prostate resection (TURP) They were prospectively randomized into a group of patients receiving finasteride (group A; 88 patients) and into a group of patients where no medication was applied until TURP (group B; 90 patients). Tissue specimens were immunohistochemically stained with monoclonal antibodies against CD34 [for microvessel density (MVD)], vascular endothelial growth factor (VEGF) and hypoxia inducible factor-1alpha (HIF-1α). Statistical analysis was performed by using the SPSS 10 program (SPSS Inc., USA). For all the tests, p<0.05 was considered as statistical significant. Our results are: Blood loss during TURP was significantly higher at group B, in comparison with group A (p<0.001). The distribution of the CD34 immunostaining was mainly at the suburethral prostate. MVD, VEGF and HIF-1a values were statistically significantly lower (p<0.001) in group A, in comparison with group B. In the finasteride group, the immunoreactivities of CD34 and HIF-1a, of VEGF and HIF1α, and of VEGF and CD34 were statistically positively correlated (p<0.001). In the same group, MVD and the expression of VEGF and HIF-1α were statistically correlated with the duration of treatment. In conclusion finasteride administration in BPH, results in statistically significant suppression of MVD, VEGF and HIF-1α, in a time dependent manner. 133
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Lekas, Alexandros
- Λέκας, Αλέξανδρος
Subjects
dc:subject × 14- Φιναστερίδη
- Καλοήθης υπερπλασία προστάτη
- Μικροαγγειακή πυκνότητα
- Αγγειακός ενδοθηλιακός αυξητικός παράγοντας (VEGF)
- Παράγοντας υποξίας 1α
- Finasteride
- Benign prostatic hyperplasia
- Microvessel density
- Vascular endothelial growth factor (VEGF)
- Hypoxia inducible factor 1α
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23624